This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
La beta apalancada y el coste de los recursos
Asquith, PaulCase HBS-205S04FinanceEl objetivo es delinear en la metodología para medir el riesgo asociado con el apalancamiento financiero y la estimación de su impacto en el costo de capital propio.Starting at €8.20
-
La reestructuración de Goodyear
Asquith, PaulCase HBS-206S04FinanceCuenta con una empresa con una estrategia exitosa de fuerte, claramente definido mercado de productos. En 1982, esta estrategia se ha ampliado con una nueva administración para incluir otros objetivos, en conflicto. Esto tiene un impacto negativo inmediato en la evaluación del mercado de valores de las acciones de Goodyear y atrae la atención de raider corporativo Sir James Goldsmith. En un intento de garantizar la independencia, responde gestión...Starting at €8.20
-
United Technologies: Are the Parts Worth More Than the Whole
Esty, Benjamin C.; Fisher, DanielCase HBS-220018-EFinanceAfter spending more than 50 years creating a diversified industrial conglomerate that Fortune Magazine described as "arguably the most profitable conglomerate in America" in 2014, UTC's CEO Greg Hayes was under pressure from activist investors (Dan Loeb aStarting at €8.20
-
Impax Laboratories: Executing Accretive Acquisitions (A)
Esty, Benjamin C.; Fisher, DanielCase HBS-220030-EFinanceImpax Laboratories was a technology-based pharmaceutical company that used a "dual platform" strategy to sell both generic and branded treatments. While Impax had grown organically for most of its history, it was beginning to use major acquisitions for growth. In the early morning of June 21, 2016, the firm issued a press release announcing it was buying a portfolio of generic drugs from Teva for $586 million in cash. The leadership team (CEO, CF...Starting at €8.20
-
Eaton Corporation: Portfolio Transformation and The Cost of Capital (Abridged)
Esty, Benjamin C.; Mayfield, E. Scott; Fisher, DanielCase HBS-221070-EFinanceIn 2000, Eaton Corporation was a broadly diversified industrial conglomerate. But its strategy was evolving and its focus was narrowing around "power management" and more recently on "intelligent power," the use of digitally enabled products and services designed to enhance efficiency and reliability. To implement this transition, Eaton had acquired more than 70 companies and divested another 50. Such active portfolio management required Eaton to...Starting at €8.20
-
Walt Disney Productions: «Greenmail» (Spanish Version)
Asquith, PaulCase HBS-202S07FinanceConsidera que una empresa cuyas estrategias de inversión en esencia se han agotado. visiones y objetivos originales de Walt Disney se han cumplido todas y después de su muerte no hay otros nuevos son próximas. Disney se enfrenta a los repetidos ataques de adquisición y se ve obligado a alguno de los conjuntos nuevos objetivos corporativos y formular una estrategia de financiación o para liquidar lentamente valor restante de la empresa a través de...Starting at €8.20
-
Impax Laboratories: Executing Accretive Acquisitions (B)
Esty, Benjamin C.; Fisher, DanielCase HBS-220031-EFinanceIExplores events after Impax announced the acquisition of a portfolio of generic pharmaceutical products from Teva in June 2016.Starting at €5.74